Alison Silva of Jupiter Neurosciences (JUNS) awarded 1.03M stock options

Rhea-AI Filing Summary

JUPITER NEUROSCIENCES, INC. reported that President and COO Alison D. Silva received a grant of stock options covering 1,027,304 shares of common stock at an exercise price of $0.2783 per share.

According to the footnote, 427,304 of these options were granted as a discretionary bonus for services during fiscal 2025, and 600,000 options were granted as long-term incentive compensation under the company’s 2025 Equity Incentive Plan. The options vest over three years, in equal quarterly installments starting on September 2, 2026, subject to continued employment, and this grant brings Silva’s reported derivative holdings to 1,027,304 options.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Silva Alison D.

Role President and COO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	1,027,304	$0.00	--

Holdings After Transaction: Stock Option — 1,027,304 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 1,027,304 options Exercise price: $0.2783 per share Discretionary bonus options: 427,304 options +3 more

6 metrics

Options granted 1,027,304 options Total stock options granted to Alison D. Silva

Exercise price $0.2783 per share Stock option exercise price for common stock

Discretionary bonus options 427,304 options Granted for services rendered during fiscal 2025

Long-term incentive options 600,000 options Granted as long-term incentive compensation

Expiration date June 2, 2036 Option expiration for this grant

Vesting start date September 2, 2026 Quarterly vesting over three years begins

Key Terms

2025 Equity Incentive Plan, discretionary bonus, long-term incentive compensation, vesting, +1 more

5 terms

2025 Equity Incentive Plan financial

"options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus"

discretionary bonus financial

"427,304 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus"

long-term incentive compensation financial

"600,000 options were granted under the Issuer's 2025 Equity Incentive Plan as long-term incentive compensation"

Long-term incentive compensation is pay awarded to executives or key employees that vests over multiple years and is tied to future company performance, often delivered as stock, options, or multi-year cash bonuses. Think of it as a multi-year reward plan that only pays out if certain goals are met, so it aligns managers’ interests with shareholders. Investors watch it because it affects future costs, share dilution and signals how leadership is motivated to grow value over time.

vesting financial

"The options vest over three years commencing from September 2, 2026 in equal quarterly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

stock option financial

"Stock Option"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silva Alison D.

(Last) (First) (Middle)

C/O JUPITER NEUROSCIENCES, INC.

1001 NORTH US HYWAY 1, SUITE 504

(Street)

JUPITER FLORIDA 33477

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.2783	06/02/2026		A		1,027,304		(1)	06/02/2036	Common Stock	1,027,304	$0	1,027,304	D

Explanation of Responses:

1. 427,304 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. 600,000 options were granted under the Issuer's 2025 Equity Incentive Plan as long-term incentive compensation. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date.

	/s/ Alison Silva	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did JUNS President and COO Alison Silva receive in this Form 4 filing?

Alison D. Silva received a grant of stock options covering 1,027,304 shares of Jupiter Neurosciences common stock. These options were awarded as compensation, including a discretionary bonus and long-term incentives, and give her the right to buy shares at a fixed exercise price.

What is the exercise price of Alison Silva’s Jupiter Neurosciences stock options?

The granted stock options have an exercise price of $0.2783 per share. This means Silva can purchase Jupiter Neurosciences common stock at that fixed price if she exercises the options after they vest, regardless of the future market price at that time.

How are the 1,027,304 JUNS stock options allocated between bonus and long-term incentives?

Out of the 1,027,304 stock options, 427,304 were granted as a discretionary bonus for fiscal 2025 services. The remaining 600,000 options were granted as long-term incentive compensation under the 2025 Equity Incentive Plan to align compensation with ongoing performance.

When do Alison Silva’s Jupiter Neurosciences options vest?

The options vest over three years in equal quarterly installments starting on September 2, 2026. Vesting is subject to Silva’s continued employment through each vesting date, meaning she must remain with the company to receive the full benefit of the grant.

When do the newly granted JUNS stock options expire?

The granted stock options expire on June 2, 2036. After that expiration date, any unexercised options will lapse and can no longer be used to purchase Jupiter Neurosciences common stock under the terms disclosed in this insider transaction report.

How many derivative securities does Alison Silva hold after this Jupiter Neurosciences grant?

Following this transaction, Silva’s reported derivative holdings total 1,027,304 stock options. This entire position reflects the newly granted options, which provide potential future equity exposure if exercised after vesting conditions are satisfied over the three-year schedule.